MIRA INFORM REPORT

 

 

Report Date :

28th June 2006

 

IDENTIFICATION DETAILS

 

Name :

SHAMROCK INTERNATIONAL LIMITED

 

 

Registered Office :

83 E, Hansraj Pragji Building, Off Dr. E. Moses Road, Worli, Mumbai – 400018, Maharashtra, India

 

 

Country :

India

 

 

Financials (as on) :

31.03.2004

 

 

Date of Incorporation :

15.03.1994

 

 

Com. Reg. No.:

11-77080

 

 

CIN No.:

[Company Identification No.]

U51900MH1994PTC077080

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS23111E

 

 

Legal Form :

A closely held public limited liability company.

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Raw Materials and Intermediary.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 950000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established company having satisfactory track.  Directors are reported as experienced, respectable and having satisfactory means of their own.  Their trade relations are fair.  Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

LOCATIONS

 

Registered Office / Marketing office :

83 E, Hansraj Pragji Building, Off Dr. E. Moses Road, Worli, Mumbai – 400018, Maharashtra, India

Tel. No.:

91-22-224904433 [8 Lines]

Fax No.:

91-22-224983300/24983344

E-Mail :

pharma@shamrockindia.com

medivet@shamrockindia.com

bpc@shamrockindia.com

Website :

http://www.shamrock.com

Area :

4,500 sq.fts.

Location :

Leased

 

 

Factory :

146, Takai Adoshi Road, Village Dheku, Taluka Khalapur, District Raigad, Khopoli, Maharashtra

 

 

Branches 1 :

1009, Maker Chamber V, 221, Nariman Point, Mumbai – 400 021, Maharashtra

Tel. No.:

91-22-22840346

Fax No.:

91-22-22853553

Area :

500 sq.fts.

Location :

Owned

 

 

Branches 2 :

2nd Floor, Shanbaug Estate, Colaba, Mumbai, Maharashtra

Area :

2,200 sq.fts.

Location :

Owned

 

DIRECTORS

 

Name :

Mr. Jitesh R. Khokhani

Designation :

Managing Director

Address :

8/9, Jeevan Vihar, Walkeshwar, Mumbai, Maharashtra, India

Date of Birth/Age :

26.04.1973

Date of Appointment :

01.08.1999

 

 

Name :

Ms. Sheetal K. Khokhani

Designation :

Director

Address :

8/9, Jeevan Vihar, Walkeshwar, Mumbai, Maharashtra, India

 

 

Name :

Mr. Chandrakant C. Chokshi

Designation :

Director

Address :

Uphar, 4th Floor, Giri Road, Malabar Hill, Mumbai – 400007, Maharashtra, India

Date of Birth/Age :

06.12.1943

Date of Appointment :

01.03.2000

 

 

Name :

Mr. Lalit K. Jain

Designation :

Company Secretary

 

MAJOR SHAREHOLDERS

 

Names of Shareholders

 

No. of Shares

Mr. Jitesh R. Khokhani

 

6,00,000

Shamrock Texyfab Limited

 

2,00,000

Shamrock Pharmaceuticals Private Limited

 

89,200

Shamrock Exports Private Limited

 

110700

Mr. Clarine H. Bole

 

80

Mr. Chandrakant C. Choksi

 

10

Ms. Usha J. Sheth

 

10

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Raw Materials and Intermediary.

 

 

Products :

>          Dyes Chemicals

>          Pharmaceuticals Raw Material

 

 

Terms :

 

Selling :

Credit (30/90 days)

 

 

Purchasing :

Credit (30/60 days)

 

PRODUCTION STATUS

 

Particulars

Unit

 

 

Installed Capacity

Pharmaceuticals Raw Materials

Litres

 

 

250000

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

105

 

 

Bankers :

v      Citibank N. A., Fort, Mumbai – 400 001, Maharashtra

(The company do not enjoys banking facility from its’ banker)

 

v      Corporation Bank

v      Global Trust Bank Limited

v      Hongkong Bank

v      ICICI Bank Limited

v      Laxmi Vilas Bank Limited

v      Oriental Bank of Commerce

v      State Bank of India

v      Union Bank of India

v      Indian Bank, Nariman Point, Mumbai-400021, Maharashtra, India

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

F. G. Pedhiwala and Company

Chartered Accountants

53, Bhajipala Lane, 2nd Floor,

Mumbai – 400 003, Maharashtra

Tel. No.:

91-22-23401861

 

 

Associates/Subsidiaries :

Shamrock Group

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

10000000

Equity Shares

Rs.10/- each

Rs. 100.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10000000

Equity Shares

Rs.10/- each

Rs. 100.000 millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2004

31.03.2003

31.03.2002

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

100.000

100.000

100.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

143.070

138.986

126.000

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

243.070

238.986

226.000

LOAN FUNDS

 

 

 

1] Secured Loans

113.550

117.668

14.553

2] Unsecured Loans

14.150

168.132

4.530

TOTAL BORROWING

127.700

285.800

19.083

DEFERRED TAX LIABILITIES

5.270

5.272

0.000

 

 

 

 

TOTAL

376.040

530.058

245.083

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

158.170

167.813

43.962

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.100

28.784

71.613

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

49.940

39.230

21.423

 

Sundry Debtors

44.770

399.320

130.957

 

Cash & Bank Balances

81.690

121.411

56.952

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

215.750

305.237

338.097

Total Current Assets

392.150

865.198

547.429

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

224.280

582.981

469.433

 

Provisions

1.880

0.800

0.800

Total Current Liabilities

226.160

583.781

470.233

Net Current Assets

165.990

281.417

77.196

 

 

 

 

MISCELLANEOUS EXPENSES

51.780

52.044

52.312

 

 

 

 

TOTAL

376.040

530.058

245.083

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2004

31.03.2003

31.03.2002

Sales Turnover [including other income]

868.160

2099.089

1125.654

 

 

 

 

Profit/(Loss) Before Tax

5.170

19.321

51.697

Provision for Taxation

1.080

--

--

Profit/(Loss) After Tax

4.090

19.321

51.697

 

 

 

 

Export Value

NA

1963.923

993.141

 

 

 

 

Import Value

NA

341.433

16.441

 

 

 

 

Total Expenditure

NA

2079.768

1073.957

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2004

31.03.2003

31.03.2002

PAT / Total Income

(%)

0.47

0.92

4.59

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

0.60

0.92

4.59

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

0.94

1.87

8.74

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.02

0.08

0.23

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.46

3.64

2.17

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.73

1.48

1.16

 

 

LOCAL AGENCY FURTHER INFORMATION

 

BUSINESS

 

Subject is engaged in the business as Manufacturer and Exporter of Pharmaceuticals Raw Materials and Intermediary.

 

It is also engaged into carry on the business as buyers, sellers, dealers and exporters of all types of commodities, crops, minerals, raw materials, semi and manufactured products, goods and ware, plant, machinery, tools and equipments, all types of fabrics made from natural and artificial fibres or a blend of natural and artificial fibres, garments, foods and beverages, etc.

 

It exports Pharmaceuticals Raw Material and Intermediary.

 

The company is in trade terms with:-

 

·         Acuatic Remedies Private Limited

218/219, Kailash Plaza, Ghatkopar (East), Mumbai, Maharashtra

      Tel. 91-22-55958111

 

·         Kapex Chemicals Private Limited

Plot No. 1, MIDC, Taloja, District– 410 200, Maharashtra

 

Profile :

 

Shamrock Industrial Company Limited {SICL} is the manufacturing division of Shamrock Group of companies, who had been primarily involved in the field of Pharmaceuticals Raw Material, Intermediates and Fine Chemicals since the past 23 years.  4 manufacturing facilities strategically located at Taloja, Chennai and Baroda in India, where they are producing high quality products an exporting them to more than 35 countries worldwide.  In fact, 100% of its sales.

 

The company at Shamrock favour a ‘Partnership’ approach with all its customers particularly for Contract Manufacturing and work closely with its ‘Partners’ to ensure smooth transactions, transparency in business and above all commitments to build a long-term relationship for the future.

 

The commitment involved in this ‘Partnership’ approach has paid rich dividends and today the company is a 100% export oriented company with several satisfied and esteemed customers which include some of the leading API Manufacturers, Multinational Companies, Leading Laboratories and Pharmaceutical Companies in more than 40 countries worldwide.

 

The company has received ISO 9000 and ISO 14000 certification.

 

Fixed assets

 

v      Computer

v      Furniture and fixtures

v      Motorcar – Opel

v      Motorcar – Safari

v      Office equipment

v      Electrical fittings.

 

 

 


CMT REPORT [Corruption, Money laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 46.34

UK Pound

1

Rs. 84.21

Euro

1

Rs. 58.14

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

4

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)                  Ownership background (20%)                         Payment record (10%)

Credit history (10%)                            Market trend (10%)                                             Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions